Chronic obstructive pulmonary disease: evaluation and management

SP Duffy, GJ Criner - Medical Clinics, 2019 - medical.theclinics.com
As the third leading cause of death in the United States in 2014, chronic obstructive
pulmonary disease (COPD) presents a significant challenge to the health care provider. 1 …

Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease

G De Rubis, KR Paudel, L Corrie, S Mehndiratta… - Naunyn-Schmiedeberg's …, 2024 - Springer
Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) are among the
leading causes of mortality worldwide. Cigarette smoking is among the main aetiologic …

Race and ethnicity in pulmonary function test interpretation: an official American Thoracic Society statement

NR Bhakta, C Bime, DA Kaminsky… - American journal of …, 2023 - atsjournals.org
Current American Thoracic Society (ATS) standards promote the use of race and ethnicity-
specific reference equations for pulmonary function test (PFT) interpretation. There is rising …

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary

CF Vogelmeier, GJ Criner, FJ Martinez… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …

Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis

MH Cho, MLN McDonald, X Zhou… - The lancet Respiratory …, 2014 - thelancet.com
Background The genetic risk factors for susceptibility to chronic obstructive pulmonary
disease (COPD) are still largely unknown. Additional genetic variants are likely to be …

[HTML][HTML] Global initiative for chronic obstructive lung disease: the changes made

AR Patel, AR Patel, S Singh, S Singh, I Khawaja - Cureus, 2019 - ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease or COPD is one of the conditions that physicians
frequently see in both the hospital and outpatient setting. In order to improve diagnostic and …

The COPD assessment test: what do we know so far?: a systematic review and meta-analysis about clinical outcomes prediction and classification of patients into …

M Karloh, AF Mayer, R Maurici, MMM Pizzichini… - Chest, 2016 - Elsevier
Background The COPD Assessment Test (CAT) was developed as a simple instrument to
assess health status in patients with COPD. This study aimed to systematically review the …

Obesity is associated with increased morbidity in moderate to severe COPD

AA Lambert, N Putcha, MB Drummond, AM Boriek… - Chest, 2017 - Elsevier
Background Obesity is prevalent in the United States; however, the impact of obesity on
COPD morbidity is unclear. We hypothesized that obesity is associated with worse outcomes …

[HTML][HTML] The German COPD cohort COSYCONET: aims, methods and descriptive analysis of the study population at baseline

A Karch, C Vogelmeier, T Welte, R Bals, HU Kauczor… - Respiratory …, 2016 - Elsevier
Abstract Background The German COPD cohort study COSYCONET (“COPD and SYstemic
consequences-COmorbidities NETwork”) investigates the interaction of lung disease …

β-Blockers are associated with a reduction in COPD exacerbations

SP Bhatt, JM Wells, GL Kinney, GR Washko, M Budoff… - Thorax, 2016 - thorax.bmj.com
Background While some retrospective studies have suggested that β-blocker use in patients
with COPD is associated with a reduction in the frequency of acute exacerbations and lower …